Insulin oral - Provalis
Alternative Names: MacrulinLatest Information Update: 21 Jan 2022
At a glance
- Originator Provalis
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 05 Feb 2008 Discontinued - Clinical-Phase-Unknown for Type-1 diabetes mellitus in USA (PO)
- 05 Feb 2008 Discontinued - Clinical-Phase-Unknown for Type-2 diabetes mellitus in USA (PO)
- 05 Feb 2008 Discontinued - Phase-II for Type-2 diabetes mellitus in Netherlands (PO)